Super Eagles of Nigeria midfielder, Fisayo Dele-Bashiru has been cleared to rejoin Lazio’s Serie A squad after working his way back to full fitness. Dele-Bashiru, 24, was removed from the club’s roster in September, shortly after picking…
A new scoring system using common clinical parameters accurately identifies chronic liver disease patients with a significantly increased risk of developing liver cancer. This tool acts as a universal predictor, helping doctors guide…
Get latest articles and stories on Business at LatestLY. Mumbai (Maharashtra) [India], November 27: In a country with over 1.4 million[i] cases reported annually, with most being reported at later stages, adaptive radiotherapy (ART) is a…
Adult patients with an aggressive form of leukemia will be able to receive a breakthrough immunotherapy, which was invented by UCL researchers, on the NHS within weeks following approval for use by the National Institute for Health and…
Cancer patients in Abuja have received a significant boost after the NNPC/Renaissance Joint Venture contributed $300,000 to the National Hospital, Abuja, ensuring the continued operation of its advanced cancer treatment equipment. The…
The NNPC/Renaissance JV donates $300,000 to sustain advanced cancer treatment in Nigeria at the National Hospital, ensuring uninterrupted patient care.
Some of the benefits of the intervention to include: treatment of over 2,000 patients, reduction of treatment cost by 80%, reduction of therapy session time from 12 minutes to 2 minutes, subsidised care for indigent patients, with 712 of…
A new study of adolescents and young adults (AYAs) with seven common cancers reveals that nearly one in ten patients diagnosed with non-metastatic disease later develop metastatic recurrence - a condition associated with significantly…
For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study published in Cell Reports, Mayo Clinic researchers have found several previously unknown genetic and cellular…
A new study of adolescents and young adults (AYAs) with seven common cancers reveals that nearly one in ten patients diagnosed with non-metastatic disease later develop metastatic recurrence—a condition associated with significantly worse…
A new immunotherapy for a severe form of blood cancer will soon be available on the NHS, offering new hope to adults whose disease has returned or stopped responding to conventional treatment.
A study of 6,800 colon cancer patients found those who took Ozempic or Mounjaro were more likely to survive the disease. It may boil down to inflammation.